[Immunopathogenesis of mucous membrane pemphigoid]

Area of Science:

• Immunodermatology
• Autoimmune blistering diseases
• Mucosal immunology

Context:

• Mucous membrane pemphigoid (MMP) presents diagnostic and therapeutic challenges.
• The precise mechanisms of MMP immunopathogenesis remain incompletely understood.
• Advances in understanding MMP are emerging from preclinical models.

Purpose:

• To detail the immunopathogenesis of mucous membrane pemphigoid (MMP).
• To explore the role of autoantibodies and immune cells in MMP.
• To evaluate a novel mouse model for studying MMP and potential treatments.

Summary:

• MMP arises from a breakdown in immune tolerance, leading to autoantibodies against basement membrane zone (BMZ) proteins.
• Autoantibody binding triggers complement deposition, inflammation, and subepithelial blistering.
• An anti-laminin 332 MMP mouse model mimics human disease, showing reduced symptoms and fibrosis with dapsone treatment.

Impact:

• Provides a better understanding of MMP's complex autoimmune mechanisms.
• Highlights the utility of preclinical models for investigating MMP.
• Offers a platform for developing and testing novel therapeutic strategies for MMP patients.